GRETCHEN BISHOP: Open Payments
NPI 1053514539 · CHICORA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 35 payments from 10 companies in 2025. Trend: 2023 $87 · 2024 $74 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $231 |
| Abbott Laboratories | 2 | $162 |
| GlaxoSmithKline, LLC. | 6 | $117 |
| Lilly USA, LLC | 4 | $77 |
| Grifols USA, LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| INOGEN, INC. | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Rybelsus, Prolastin-C Liquid, Ozempic, MOUNJARO, Wegovy, BREZTRI.
Industry payments across PA — which companies pay providers there.
